Metabolic Changes During Gonadotropin-releasing Hormone Agonist Therapy for Prostate Cancer: Differences From the Classic Metabolic Syndrome

BACKGROUND: In men with prostate cancer, gonadotropin-releasing hormone (GnRH) agonists increase fat mass, decrease insulin sensitivity, and increase triglycerides, features that are shared with metabolic syndrome. To the authors’ knowledge, however, less is known regarding the effects of GnRH agoni...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Smith, Matthew R., Lee, Hang, McGovern, Francis, Fallon, Mary Anne, Goode, Melissa, Zietman, Anthony L., Finkelstein, Joel S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2562782/
https://ncbi.nlm.nih.gov/pubmed/18348297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23440
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg